» Articles » PMID: 23406336

Next Generation Sequencing in Cancer Research and Clinical Application

Overview
Publisher Biomed Central
Date 2013 Feb 15
PMID 23406336
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

The wide application of next-generation sequencing (NGS), mainly through whole genome, exome and transcriptome sequencing, provides a high-resolution and global view of the cancer genome. Coupled with powerful bioinformatics tools, NGS promises to revolutionize cancer research, diagnosis and therapy. In this paper, we review the recent advances in NGS-based cancer genomic research as well as clinical application, summarize the current integrative oncogenomic projects, resources and computational algorithms, and discuss the challenge and future directions in the research and clinical application of cancer genomic sequencing.

Citing Articles

Whole-Exome Analysis and Osteosarcoma: A Game Still Open.

Chiappetta C, Della Rocca C, Di Cristofano C Int J Mol Sci. 2025; 25(24.

PMID: 39769419 PMC: 11728052. DOI: 10.3390/ijms252413657.


Case report: Dramatic impact of DNA next generation sequencing results using specific targeted therapies- and .

Cullum S, Vang H, Glover M, Alammarah H, Morton H, Pham N Front Oncol. 2024; 14:1462930.

PMID: 39659799 PMC: 11628483. DOI: 10.3389/fonc.2024.1462930.


Assessing the complementary information from an increased number of biologically relevant features in liquid biopsy-derived RNA-Seq data.

Giannoukakos S, DAmbrosi S, Koppers-Lalic D, Gomez-Martin C, Fernandez A, Hackenberg M Heliyon. 2024; 10(6):e27360.

PMID: 38515664 PMC: 10955244. DOI: 10.1016/j.heliyon.2024.e27360.


Spatial transcriptomics in glioblastoma: is knowing the right zip code the key to the next therapeutic breakthrough?.

Shireman J, Cheng L, Goel A, Garcia D, Partha S, Quinones-Hinojosa A Front Oncol. 2023; 13:1266397.

PMID: 37916170 PMC: 10618006. DOI: 10.3389/fonc.2023.1266397.


Genomic, transcriptomic and epigenomic sequencing data of the B-cell leukemia cell line REH.

Lysenkova Wiklander M, Overnas E, Lagensjo J, Raine A, Petri A, Wiman A BMC Res Notes. 2023; 16(1):265.

PMID: 37817248 PMC: 10566058. DOI: 10.1186/s13104-023-06537-2.


References
1.
Seshagiri S, Stawiski E, Durinck S, Modrusan Z, Storm E, Conboy C . Recurrent R-spondin fusions in colon cancer. Nature. 2012; 488(7413):660-4. PMC: 3690621. DOI: 10.1038/nature11282. View

2.
Trapnell C, Hendrickson D, Sauvageau M, Goff L, Rinn J, Pachter L . Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol. 2012; 31(1):46-53. PMC: 3869392. DOI: 10.1038/nbt.2450. View

3.
Dobin A, Davis C, Schlesinger F, Drenkow J, Zaleski C, Jha S . STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2012; 29(1):15-21. PMC: 3530905. DOI: 10.1093/bioinformatics/bts635. View

4.
Wong W, Kim D, Carter H, Diekhans M, Ryan M, Karchin R . CHASM and SNVBox: toolkit for detecting biologically important single nucleotide mutations in cancer. Bioinformatics. 2011; 27(15):2147-8. PMC: 3137226. DOI: 10.1093/bioinformatics/btr357. View

5.
Brosnan J, Iacobuzio-Donahue C . A new branch on the tree: next-generation sequencing in the study of cancer evolution. Semin Cell Dev Biol. 2012; 23(2):237-42. PMC: 3314157. DOI: 10.1016/j.semcdb.2011.12.008. View